The effect of the immunomodulator AS101 on Parkinson's disease

被引：0
作者：
Gefen, R [1 ]
Yadid, G [1 ]
Shalit, F [1 ]
Sredni, B [1 ]
机构：
[1] Bar Ilan Univ, CAIR Inst, Marilyn Finkler Canc Res Ctr, Dept Life Sci, Ramat Gan, Israel
来源：
EUROPEAN CYTOKINE NETWORK | 1998年 / 9卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
351
引用
收藏
页码：541 / 541
页数：1
相关论文
共 50 条
[21]   PRE-TRANSPLANT DESENSITIZATION USING THE IMMUNOMODULATOR AS101: PRELIMINARY IN-VITRO RESULTS [J].
Israeli, Moshe ;
Sredni, Benjamin ;
Mor, Eitan ;
Zakai, Chana ;
Klein, Tirza .
HUMAN IMMUNOLOGY, 2009, 70 :S158-S158
[22]   INCREASED DNA-REPAIR ABILITY AFTER IRRADIATION FOLLOWING TREATMENT WITH THE IMMUNOMODULATOR AS101 [J].
KALECHMAN, Y ;
SHANI, A ;
ALBECK, M ;
BARKAI, IS ;
SREDNI, B .
RADIATION RESEARCH, 1993, 136 (02) :197-204
[23]   The tellurium-based immunomodulator, AS101 ameliorates adjuvant-induced arthritis in rats [J].
Halpert, G. ;
Halperin Sheinfeld, M. ;
Monteran, L. ;
Sharif, K. ;
Volkov, A. ;
Nadler, R. ;
Schlesinger, A. ;
Barshak, I. ;
Kalechman, Y. ;
Blank, M. ;
Shoenfeld, Y. ;
Amital, H. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2021, 203 (03) :375-384
[24]   A novel treatment for Parkinson's disease using an immunomodulator [J].
Sredni, B ;
Yadid, G ;
Albeck, M ;
Shalit, F ;
Gefen, R .
JOURNAL OF NEUROCHEMISTRY, 2003, 85 :40-40
[25]   Neutral and positively charged thiols synergize the effect of the immunomodulator AS101 as a growth inhibitor of Jurkat cells, by increasing its uptake [J].
Frei, Gabi M. ;
Lebenthal, Ilana ;
Albeck, Michael ;
Albeck, Amnon ;
Sredni, Benjamin .
BIOCHEMICAL PHARMACOLOGY, 2007, 74 (05) :712-722
[26]   A novel treatment for Parkinson's disease using an immunomodulator [J].
Sredni, B ;
Yadid, G ;
Albeck, M ;
Shalit, F ;
Gefen, R .
JOURNAL OF NEUROCHEMISTRY, 2003, 85 :90-90
[27]   INDUCTION OF ACUTE-PHASE PROTEINS IN MICE AND HUMANS BY TREATMENT WITH AS101, AND IMMUNOMODULATOR WITH RADIOPROTECTIVE PROPERTIES [J].
SREDNI, B ;
ALBECK, M ;
KALECHMAN, Y .
HEPATOLOGY, 1994, 19 (04) :I126-I126
[28]   The immunomodulator AS101 induces growth arrest and apoptosis in Multiple Myeloma: Association with the Akt/Survivin pathway [J].
Hayun, Michal ;
Naor, Yaniv ;
Weil, Merav ;
Albeck, Michael ;
Peled, Alpha ;
Don, Jeremy ;
Haran-Ghera, Nechama ;
Sredni, Benjamin .
BIOCHEMICAL PHARMACOLOGY, 2006, 72 (11) :1423-1431
[29]   CYTOKINE SECRETION EFFECTED BY SYNERGISM OF THE IMMUNOMODULATOR AS101 AND THE PROTEIN-KINASE-C INDUCER BRYOSTATIN [J].
SREDNI, B ;
KALECHMAN, Y ;
ALBECK, M ;
GROSS, O ;
AURBACH, D ;
SHARON, P ;
SEHGAL, SN ;
GURWITH, MJ ;
MICHLIN, H .
IMMUNOLOGY, 1990, 70 (04) :473-477
[30]   INDUCTION OF ACUTE-PHASE PROTEINS IN MICE AND HUMANS BY TREATMENT WITH AS101, AN IMMUNOMODULATOR WITH RADIOPROTECTIVE PROPERTIES [J].
KALECHMAN, Y ;
SHANI, A ;
ALBECK, M ;
SREDNI, B .
IMMUNOPHARMACOLOGY, 1995, 29 (02) :149-158
12345